Multiple Sclerosis - This is a chronic inflammatory autoimmune disease of the central nervous system. It has been found that the earlier a patient receives stem cells for this condition, the better the outcome of the treatment, if there is a response.

Investor Relations to a Human Stem Cell Research Clinics, Treatment for Diseases, MS, Parkinsons, Diabetes Treatment

Investor Information


Investor Relations and Global Partner Program

For any questions about Investor Relations and our Global Partner Program please contact:
Walter Kravchenko
Chairman & CEO


4474 Middle Country Road
Calverton, NY 11933 USA


Direct: (631) 929-3900
Fax: (631) 929-3909